Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1 Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1 Bth allele into the cochlea of neonatal Tmc1 Bth/+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1 Bth/+ mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, lipid-mediated nanoparticle (LNP) delivery has been used to transport CRISPR-Cas components in the form of either mRNA/sgRNA or preassembled RNPs into tissues 71-74 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [74]
In the citing paper
“Additionally, lower auditory response thresholds and improved acoustic responses were observed in injected mice.[226]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [226]
In the citing paper
“The intraaural injection of Cas9 RNPs/lipofectamine 2000 complexes into the scala media of neonatal Tmc1Bth/+ mice significantly increased the survival of hair cells.”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [226]
In the citing paper
“All these results demonstrated that this system substantially reduced progressive hearing loss in Beethoven mouse model (Fig. 3B) [113].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268 · cited 4×
“We identified three candidate sgRNAs (Tmc1-mut1, Tmc1-mut2, and Tmc1-mut3) that place the Bth mutation at position 11, 12, or 15, respectively, of the spacer, counting the PAM as positions 21-23 (Fig.”
InfluentialImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 1×
“A fourth sgRNA, Tmc1-mut4, is a truncated version of Tmc1-mut3 designed to increase genome editing DNA specificity 22 .”
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
Newborn Hearing Screening — A Silent Revolution
Morton, C. C., & Nance, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050700 · Cited by 1,686
Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487
Self-citationZuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Self-citationCRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,013
Self-citationLong, C., Amoasii, L., Mireault, A. A., McAnally, J. R., Li, H., Sanchez-Ortiz, E., Bhattacharyya, S., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2016) · Science · doi:10.1126/science.aad5725 · Cited by 937
Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3471 · Cited by 876
Self-citationEfficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
Wang, M., Zuris, J. A., Meng, F., Rees, H., Sun, S., Deng, P., Han, Y., Gao, X., Pouli, D., Wu, Q., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520244113 · Cited by 624
Self-citation
Cited by
Items 201–300 of 566
Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
Zhou, L., & Yao, S. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00115-5 · Cited by 33
Current Advances in Gene Therapies of Genetic Auditory Neuropathy Spectrum Disorder
Saidia, A. R., Ruel, J., Bahloul, A., Chaix, B., Venail, F., & Wang, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030738 · Cited by 33
Transcription factor induced conversion of human fibroblasts towards the hair cell lineage
Alonso, M. B. D., López‐Hernández, I., de la Fuente, M. Á., García-Sancho, J., Giráldez, F., & Schimmang, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200210 · Cited by 33
Botto, C., Dalkara, D., & El-Amraoui, A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.737632 · Cited by 32
One-in-one individual package and delivery of CRISPR/Cas9 ribonucleoprotein using apoferritin
Pan, X., Pei, X., Huang, H., Su, N., Wu, Z., Wu, Z., & Qi, X. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.015 · Cited by 32
The pathogenesis of common Gjb2 mutations associated with human hereditary deafness in mice
Li, Q., Cui, C., Liao, R., Yin, X., Wang, D., Cheng, Y., Huang, B., Wang, L., Yan, M., Zhou, J., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04794-9 · Cited by 32
Self-citationStem cell-based approaches: Possible route to hearing restoration?
Alonso, M. B. D. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i6.422 · Cited by 32
Gene Therapy in Mouse Models of Deafness and Balance Dysfunction
Wang, L., Kempton, J. B., & Brigande, J. V. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00300 · Cited by 31
Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1
Marsh, S., Hanson, B., Wood, M. J. A., Varela, M. A., & Roberts, T. C. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.005 · Cited by 31
Homology-directed repair of an MYBPC3 gene mutation in a rat model of hypertrophic cardiomyopathy
Nie, J., Han, Y., Jin, Z., Hang, W., Shu, H., Zheng, W., Ni, L., & Wang, D. W. (2023) · Gene Therapy · doi:10.1038/s41434-023-00384-3 · Cited by 31
Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy
de Joya, E. M., Colbert, B., Tang, P.-C., Lam, B. L., Yang, J., Blanton, S. H., Dykxhoorn, D. M., & Liu, X. Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083910 · Cited by 31
Non-syndromic hearing loss: clinical and diagnostic challenges
Vona, B., Doll, J., Hofrichter, M. A. H., & Haaf, T. (2020) · Medizinische Genetik · doi:10.1515/medgen-2020-2022 · Cited by 31
In vivo production of CAR T cell: Opportunities and challenges
Song, Z., Zhou, Y., Wang, B., Geng, Y., Tang, G., Wang, Y., & Yang, J. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101612 · Cited by 30
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations
Chaugule, S. R., Constantinou, C. K., John, A. A., Micha, D., Eekhoff, E. M. W., Gravallese, E. M., Gao, G., & Shim, J. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.191 · Cited by 30
Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss
Lye, J., Delaney, D. S., Leith, F. K., Sardesai, V. S., McLenachan, S., Chen, F. K., Atlas, M. D., & Wong, E. Y. M. (2023) · Biomedicines · doi:10.3390/biomedicines11123347 · Cited by 30
Yang, X., Zhou, S., Zeng, J., Zhang, S., Li, M., Yue, F., Chen, Z., Dong, Y., Zeng, Y., & Luo, J. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.10.030 · Cited by 30
Self-citationConversations in Cochlear Implantation: The Inner Ear Therapy of Today
Rauterkus, G. P., Maxwell, A. K., Kahane, J. B., Lentz, J. J., & Arriaga, M. A. (2022) · Biomolecules · doi:10.3390/biom12050649 · Cited by 30
Gene editing innovations and their applications in cardiomyopathy research
Kyriakopoulou, E., Monnikhof, T., & van Rooij, E. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050088 · Cited by 29
Aljanahi, A. A., Lazzarotto, C. R., Chen, S., Shin, T., Cordes, S., Fan, X., Jabara, I., Zhou, Y., Young, D. J., Lee, B., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.016 · Cited by 29
Self-citationUnderstanding and treating paediatric hearing impairment
Wrobel, C., Zafeiriou, M.-P., & Moser, T. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2020.103171 · Cited by 29
AlleleAnalyzer: a tool for personalized and allele-specific sgRNA design
Keough, K. C., Lyalina, S., Olvera, M. P., Whalen, S., Conklin, B. R., & Pollard, K. S. (2019) · Genome biology · doi:10.1186/s13059-019-1783-3 · Cited by 29
Advances in CRISPR/Cas gene therapy for inborn errors of immunity
Liu, X., Li, G., Liu, Y., Zhou, F., Huang, X., & Li, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111777 · Cited by 28
Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine
Dai, X., Blancafort, P., Wang, P., Sgro, A., Thompson, E. W., & Ostrikov, K. (2020) · Advanced Science · doi:10.1002/advs.201902552 · Cited by 28
Innovations in CRISPR technology
Brooks, A. K., & Gaj, T. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.03.007 · Cited by 28
Gu, X. G., Hu, X., Wang, D., Xu, Z., Wang, F., Li, D., Li, G., Yang, H., Li, H., Zuo, E., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00624-y · Cited by 28
Self-citationFetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction
Hastings, M. L., & Brigande, J. V. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107931 · Cited by 29
Nanomaterials for Inner Ear Diseases: Challenges, Limitations and Opportunities
Li, L., Luo, J., Lin, X., Tan, J., & Li, P. (2022) · Materials · doi:10.3390/ma15113780 · Cited by 28
Breakthrough Moments: Genome Editing and Organoids
Roper, J., & Yilmaz, Ö. H. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.008 · Cited by 27
Lipid and polymer mediated CRISPR/Cas9 gene editing
Gong, Y., Tian, S., Yang, X., & Zhang, S. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00207k · Cited by 27
Taharabaru, T., Yokoyama, R., Higashi, T., Mohammed, A. F. A., Inoue, M., Maeda, Y. K., Niidome, T., Onodera, R., & Motoyama, K. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b21667 · Cited by 27
Inner ear gene delivery: vectors and routes
Valentini, C., Szeto, B., Kysar, J. W., & Lalwani, A. K. (2020) · Hearing Balance and Communication · doi:10.1080/21695717.2020.1807261 · Cited by 27
Identification of four TMC 1 variations in different Chinese families with hereditary hearing loss
Wang, H., Wu, K., Guan, J., Yang, J. D., Xie, L., Xiong, F., Lan, L., Wang, D., & Wang, Q. (2018) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.394 · Cited by 27
Self-citationWu, T., Cao, Y., Liu, Q. L., Wu, X., Shang, Y., Piao, J., Li, Y., Dong, Y., Liu, D., Wang, H., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c01760 · Cited by 26
Self-citationLi, Y., Li, R., Chakraborty, A., Ogurlu, R., Zhao, X., Chen, J., & Xu, Q. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00295 · Cited by 26
Self-citationCurrent AAV-mediated gene therapy in sensorineural hearing loss
Qi, J., Fu, X., Zhang, L., Tan, F., Li, N., Sun, Q., Hu, X., He, Z., Xia, M., & Chai, R. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.08.015 · Cited by 26
Rational Design of Inner Ear Drug Delivery Systems
Maimaitikelimu, X., Xuan, Z., Ren, H., Chen, K., Zhang, H., & Wang, H. (2025) · Advanced Science · doi:10.1002/advs.202410568 · Cited by 26
Self-citationMesenchymal stem cells for sensorineural hearing loss: a systematic review of preclinical studies
Chorath, K. T., Willis, M., Morton-Gonzaba, N., & Moreira, A. G. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05460-0 · Cited by 26
Extracellular vesicles for developing targeted hearing loss therapy
Pan, X., Li, Y., Huang, P., Staecker, H., & He, M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.050 · Cited by 25
Self-citationChen, Y., Luo, X. L., Kang, R., Cui, K., Ou, J., Zhang, X., & Liang, P. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.07.007 · Cited by 25
Gene Therapy to the Retina and the Cochlea
Crane, R., Conley, S. M., Al‐Ubaidi, M. R., & Naash, M. I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.652215 · Cited by 25
Prevalence and clinical features of autosomal dominant and recessive TMC1-associated hearing loss
Nishio, S., & Usami, S. (2021) · Human Genetics · doi:10.1007/s00439-021-02364-2 · Cited by 25
Recent development of AAV-based gene therapies for inner ear disorders
Lan, Y., Tao, Y., Wang, Y., Ke, J., Yang, Q., Liu, X., Su, B., Wu, Y., Lin, C., & Zhong, G. (2020) · Gene Therapy · doi:10.1038/s41434-020-0155-7 · Cited by 25
Self-citationPan, X., Huang, P., Ali, S., Renslo, B., Hutchinson, T. E., Erwin, N., Greenberg, Z., Ding, Z., Li, Y., Warnecke, A., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adn3993 · Cited by 24
Self-citationInner Ear Gene Therapy: An Overview from Bench to Bedside
Gadenstaetter, A. J., Krumpoeck, P. E., & Landegger, L. D. (2024) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-024-00759-1 · Cited by 24
Kang, W., Zhao, X., Sun, Z., Dong, T., Jin, C., Tong, L., Zhu, W., Tao, Y., & Wu, H. (2020) · Gene Therapy · doi:10.1038/s41434-020-0124-1 · Cited by 24
Self-citationPaßreiter, A., Thomas, A., Grogna, N., Delahaut, P., & Thevis, M. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04445 · Cited by 24
Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
Hastings, M. L., & Jones, T. A. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00729-0 · Cited by 24
The Genomics of Auditory Function and Disease
Taiber, S., Gwilliam, K., Hertzano, R. P., & Avraham, K. B. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-121321-094136 · Cited by 24
Neural presbycusis at ultra-high frequency in aged common marmosets and rhesus monkeys
Sun, Z., Cheng, Z., Gong, N., Xu, Z., Jin, C., Wu, H., & Tao, Y. (2021) · Aging · doi:10.18632/aging.202936 · Cited by 24
Self-citationDual-gRNA approach with limited off-target effect corrects C9ORF72 repeat expansion in vivo
Piao, X., Meng, D., Zhang, X., Song, Q., Lv, H., & Jia, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-07746-8 · Cited by 23
Ricci, R., & Colasante, G. (2021) · Developmental Neuroscience · doi:10.1159/000515845 · Cited by 23
rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application
Blanc, F., Mondain, M., Bemelmans, A., Affortit, C., Puel, J., & Wang, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020589 · Cited by 23
Lustig, L. R., & Akil, O. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a033191 · Cited by 23
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches
Sun, Y., Li, L., Wang, J., Liu, H., & Wang, H. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00324 · Cited by 23
Self-citationTreating Hearing Loss: From Cochlear Implantation to Gene Therapy
Zeng, F., Qi, J., Wu, C., Shu, Y., & Chai, R. (2025) · Advanced Science · doi:10.1002/advs.202509960 · Cited by 23
Self-citationQiu, Y., Wang, H., Fan, M., Pan, H., Guan, J., Jiang, Y., Jia, Z., Wu, K., Zhou, H., Zhuang, Q., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05899-6 · Cited by 23
Self-citationAuditory Brainstem Response (ABR) Measurements in Small Mammals
Kim, Y.-H., Schrode, K. M., & Lauer, A. M. (2022) · Neuromethods · doi:10.1007/978-1-0716-2022-9_16 · Cited by 23
Seo, S.-Y., Min, S., Lee, S., Seo, J. H., Park, J., Kim, H. K., Song, M., Baek, D., Cho, S., & Kim, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01875-2 · Cited by 22
Toward the Treatment of Inherited Diseases of the Retina Using CRISPR-Based Gene Editing
Hernández-Juárez, J., Rodríguez‐Uribe, G., & Borooah, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.698521 · Cited by 22
Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges
Taiber, S., & Avraham, K. B. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134527 · Cited by 22
Reversal of hepatic fibrosis by the co-delivery of drug and ribonucleoprotein-based genome editor
Gu, J., Sun, J., Tian, K. V., Bian, J., Peng, J., Xu, S. Q., & Zhao, L. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122133 · Cited by 22
Shah, V., Mittal, R., Shahal, D., Sinha, P., Bulut, E., Mittal, J., & Eshraghi, A. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00113 · Cited by 22
Interaction-aware dexterous robot for minimally invasive transcanal inner ear interventions
Li, H., Gao, P., Tan, H., Li, H., Zhu, H., Jiang, M., Ni, Y., He, Y., Huang, J., Zhu, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72398-5 · Cited by 22
Wu, X., Zhang, W., Li, Y., & Lin, X. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00529 · Cited by 22
Self-citationMethods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo
Bykonya, A. G., Лавров, А. В., & Smirnikhina, S. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00479-z · Cited by 21
The rise of cochlear gene therapy
Landegger, L. D., Reisinger, E., Lallemend, F., Hage, S. R., Grimm, D., & Cederroth, C. R. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.012 · Cited by 21
CRISPR delivery systems for organ-specific targeting: Advances and challenges
Du, J., Wu, Q., Liu, C., Wang, N., & Gong, C. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100048 · Cited by 21
Blossom of CRISPR technologies and applications in disease treatment
Liu, H., Wang, L., & Luo, Y. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.10.003 · Cited by 21
Roccio, M. (2020) · Stem Cells · doi:10.1002/stem.3315 · Cited by 21
Zhao, X., Jin, C., Dong, T., Sun, Z., Zheng, X., Feng, B., Cheng, Z., Li, X. O., Tao, Y., & Wu, H. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107999 · Cited by 21
Self-citationWang, Y., Liu, Z., Zhang, H., Liu, J., Dai, H., Ji, T., Liu, F., Cao, P., Zou, J., Wang, S., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134992 · Cited by 21
Debugging the genetic code: Non-viral in vivo delivery of therapeutic genome editing technologies
Piotrowski-Daspit, A. S., Glazer, P. M., & Saltzman, W. M. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.08.002 · Cited by 21
Feng, B., Dong, T., Song, X., Zheng, X., Jin, C., Cheng, Z., Liu, Y., Zhang, W., Wang, X., Tao, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202305682 · Cited by 21
Self-citationHan, L., Wang, Z., Wang, D., Gao, Z., Hu, S., Shi, D., & Shu, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1305433 · Cited by 20
Self-citationTemblador, A., Topalis, D., Andreï, G., & Snoeck, R. (2019) · Cancers · doi:10.3390/cancers11091260 · Cited by 20
Milestones toward cochlear gene therapy for patients with hereditary hearing loss
Yoshimura, H., Nishio, S., & Usami, S. (2021) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.633 · Cited by 20
Gene therapy for retinal dystrophy
Sahel, J., & Dalkara, D. (2019) · Nature Medicine · doi:10.1038/s41591-019-0346-1 · Cited by 19
Zhao, W., La, Z., Guo, J., Xu, Q., Zhang, M., Liu, H., Ren, C., Zhao, Y., Wang, J., Peng, Q., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202418090 · Cited by 19
Self-citationPhenotypic variability to medication management: an update on fragile X syndrome
Elhawary, N. A., AlJahdali, I. A., Abumansour, I. S., Azher, Z. A., Falemban, A. H., Madani, W. M., Alosaimi, W., Alghamdi, G., & Sindi, I. A. (2023) · Human Genomics · doi:10.1186/s40246-023-00507-2 · Cited by 19
Widely used gene editing strategies in cancer treatment a systematic review
Suleiman, A. A., Saedi, W. Y., & Muhaidi, M. J. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100983 · Cited by 19
Suresh, K., & Pillai, D. (2023) · Biologia · doi:10.1007/s11756-023-01454-y · Cited by 19
A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
Porter, S. N., Levine, R. M., & Pruett‐Miller, S. M. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180022 · Cited by 18
DNA Nanocarriers for Delivery of sgRNA/Cas9 Ribonucleoprotein
Zhu, H., Fan, J., Yang, C., Liu, J., & Ding, B. (2024) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2024.9290096 · Cited by 18
Chitosan-Based Nanocomposites for Biological Applications
Yalçın, S., & Çankaya, N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106379 · Cited by 18
Practical aspects of inner ear gene delivery for research and clinical applications
Lee, S., Dondzillo, A., Gubbels, S. P., & Raphael, Y. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107934 · Cited by 18
Distributional comparison of different AAV vectors after unilateral cochlear administration
Han, S., Xu, Z., Wang, S., Tang, H., Hu, S., Wang, H., Guan, G., & Shu, Y. (2023) · Gene Therapy · doi:10.1038/s41434-023-00431-z · Cited by 18
Self-citationHearing Loss: Genetic Testing, Current Advances and the Situation in Latin America
Rosa, M. A. D., Bernardi, M. T., Kleppe, S., & Walz, K. (2024) · Genes · doi:10.3390/genes15020178 · Cited by 18
International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials
Fan, X., Gao, Z., Zhong, J., Chen, Y., Chen, X., Landegger, L. D., Moser, T., Zeng, F., Sun, Y., Jin, X., et al. (2025) · Med · doi:10.1016/j.medj.2025.100886 · Cited by 18
Self-citationWu, F., He, W., Xiao, Y., Wu, Q., Zhang, Q., Zhang, T., Xu, L., & Pang, X. (2025) · Advanced Science · doi:10.1002/advs.202408397 · Cited by 17
Latest progress in the study of nanoparticle-based delivery of the CRISPR/Cas9 system
Yu, M., Liu, X., Cheng, H., Kuang, L., Zhang, S., & Yan, X. (2021) · Methods · doi:10.1016/j.ymeth.2021.06.004 · Cited by 17
Phan, H. T. L., Kim, K., Lee, H., & Seong, J. K. (2023) · Genes · doi:10.3390/genes14020483 · Cited by 18
Polyrotaxane-based multi-step transformable materials for the delivery of Cas9 ribonucleoprotein
Taharabaru, T., Kihara, T., Onodera, R., Kogo, T., Higashi, K., Moribe, K., Nakamura, T., Motoyama, K., & Higashi, T. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101488 · Cited by 17
Zhang, Y., Li, Z., Essola, J. M., Ge, K., Dai, X., He, H., Xiao, H., Weng, Y., & Huang, Y. (2022) · Biosafety and Health · doi:10.1016/j.bsheal.2022.03.010 · Cited by 17
Supramolecular Nanosubstrate‐Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion
Ban, Q., Yang, P., Chou, S., Qiao, L., Xia, H., Xue, J., Wang, F., Xu, X., Sun, N., Zhang, R. Y., et al. (2021) · Small · doi:10.1002/smll.202100546 · Cited by 17
Self-citationTriple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases
Zhang, L., Wang, L., Xie, Y., Wang, P., Deng, S., Qin, A., Zhang, J., Yu, X., Zheng, W., & Jiang, X. (2019) · Angewandte Chemie · doi:10.1002/ange.201903618 · Cited by 17
A New Approach to Treating Neurodegenerative Otologic Disorders
Moos, W. H., Faller, D. V., Glavas, I. P., Harpp, D. N., Irwin, M. H., Kanara, I., Pinkert, C. A., Powers, W. R., Steliou, K., Vavvas, D. G., et al. (2018) · BioResearch open access · doi:10.1089/biores.2018.0017 · Cited by 17
Combinatorial Library of Light-Cleavable Lipidoid Nanoparticles for Intracellular Drug Delivery
Li, Y., Chakraborty, A., Chen, J., & Xu, Q. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00445 · Cited by 17
Self-citationHearing Phenotypes of Patients with Hearing Loss Homozygous for the GJB2 c.235delc Mutation
Guo, C., Huang, S.-S., Yuan, Y., Zhou, Y., Wang, N., Kang, D., Yang, S., Zhang, X., Gao, X., & Dai, P. (2020) · Neural Plasticity · doi:10.1155/2020/8841522 · Cited by 16
Self-citationEngineering CRISPR-Cas9 RNA–Protein Complexes for Improved Function and Delivery
Rouet, R., de Oñate, L., Li, J., Murthy, N., & Wilson, R. C. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0037 · Cited by 16
Li, Y., Weng, Y., Bai, D., Jia, Y., Liu, Y., Zhang, Y., Kou, X., Zhao, Y., Ruan, J., Chen, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18391-y · Cited by 16
Self-citation
Metadata
- Authors
- Gao, X., Tao, Y., Lamas, V., Huang, M., Yeh, W.-H., Pan, B., Hu, Y.-J., Hu, J. H., Thompson, D. B., Shu, Y., Li, Y., Wang, H., Yang, S., Xu, Q., Polley, D. B., Liberman, M. C., Kong, W.-J., Holt, J. R., Chen, Z.-Y., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Massachusetts Eye and Ear Infirmary (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Tufts University (US)
- Corresponding author
- Chen, Zheng-Yi
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7687
- Pages
- 217-221
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5784267
- OpenAlex
- W2778806019
- Cited by
- 536
- References
- 28
- Citations by year
- 2026: 25 · 2025: 43 · 2024: 58 · 2023: 62 · 2022: 64 · 2021: 60 · 2020: 101 · 2019: 67 · 2018: 54 · 2017: 1
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (2r01dc013521-11a1)
- National Institute on Deafness and Other Communication Disorders (R01-DC013521, R01DC009836, P30DC005209, R01DC006908, F32DC000138, R01DC000188)
- National Institute of General Medical Sciences (R35GM118062)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- autosomal dominant hearing loss, CRISPR/Cas9 genome editing, in vivo gene delivery, dominant negative mutation, auditory brainstem response, acoustic startle response
- MeSH terms
- Gene Editing, Acoustic Stimulation, Alleles, Animals, Animals, Newborn, Auditory Threshold, Base Sequence, Cell Survival, Cochlea, Disease Models, Animal, Female, Fibroblasts, Genes, Dominant, Hair Cells, Auditory, Humans, Liposomes, Male, Membrane Proteins, Reflex, Startle, Genetic Therapy, Evoked Potentials, Auditory, Brain Stem, Hearing Loss, Mice, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.